Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026)
Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,806.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -987.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 3,232.00 |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | 1,953.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,953.00 |
| Dec 31, 2025 | 1,381.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 1,058.00 |
| Mar 31, 2025 | 36,089.00 |
| Dec 31, 2024 | 7,220.00 |
| Sep 30, 2024 | 10,705.00 |
| Jun 30, 2024 | -7,574.00 |
| Mar 31, 2024 | -6.00 |
| Dec 31, 2023 | 1,221.00 |
| Sep 30, 2023 | 84.00 |
| Jun 30, 2023 | -73.00 |
| Mar 31, 2023 | -1,263.00 |
| Dec 31, 2022 | -259.00 |
| Sep 30, 2022 | 873.00 |
| Jun 30, 2022 | 208.00 |
| Mar 31, 2022 | -34,651.00 |
| Dec 31, 2021 | -7,769.00 |
| Sep 30, 2021 | 3,372.00 |
| Jun 30, 2021 | 10,711.00 |